Baker Ellis Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.28M | Sell |
14,950
-300
| -2% | -$46K | 0.27% | 77 |
|
|
2025
Q4 | $2.1M | Buy |
15,250
+539
| +4% | +$70.6K | 0.25% | 78 |
|
|
2025
Q3 | $1.89M | Buy |
14,711
+150
| +1% | +$18.3K | 0.23% | 80 |
|
|
2025
Q2 | $1.76M | Buy |
14,561
+2,200
| +18% | +$248K | 0.24% | 76 |
|
|
2025
Q1 | $1.38M | Buy |
12,361
+1,034
| +9% | +$110K | 0.2% | 92 |
|
|
2024
Q4 | $1.1M | Sell |
11,327
-557
| -5% | -$59.4K | 0.16% | 94 |
|
|
2024
Q3 | $1.37M | Sell |
11,884
-125
| -1% | -$14.2K | 0.19% | 91 |
|
|
2024
Q2 | $1.28M | Sell |
12,009
-160
| -1% | -$16.1K | 0.19% | 90 |
|
|
2024
Q1 | $1.18M | Sell |
12,169
-600
| -5% | -$61.5K | 0.18% | 103 |
|
|
2023
Q4 | $1.29M | Hold |
12,769
| – | – | 0.21% | 92 |
|
|
2023
Q3 | $1.3M | Sell |
12,769
-250
| -2% | -$25.4K | 0.23% | 85 |
|
|
2023
Q2 | $1.31M | Sell |
13,019
-100
| -0.8% | -$10K | 0.22% | 86 |
|
|
2023
Q1 | $1.21M | Sell |
13,119
-500
| -4% | -$43.7K | 0.22% | 89 |
|
|
2022
Q4 | $1.24M | Sell |
13,619
-123
| -0.9% | -$10.4K | 0.24% | 83 |
|
|
2022
Q3 | $1.04M | Sell |
13,742
-153
| -1% | -$12.7K | 0.23% | 84 |
|
|
2022
Q2 | $1.18M | Buy |
13,895
+26
| +0.2% | +$2.28K | 0.24% | 83 |
|
|
2022
Q1 | $1.22M | Buy |
13,869
+100
| +0.7% | +$8.66K | 0.22% | 89 |
|
|
2021
Q4 | $1.2M | Sell |
13,769
-260
| -2% | -$21.6K | 0.21% | 91 |
|
|
2021
Q3 | $1.15M | Sell |
14,029
-479
| -3% | -$43.1K | 0.22% | 92 |
|
|
2021
Q2 | $1.32M | Sell |
14,508
-3,301
| -19% | -$294K | 0.26% | 83 |
|
|
2021
Q1 | $1.52M | Sell |
17,809
-920
| -5% | -$82.6K | 0.33% | 75 |
|
|
2020
Q4 | $1.77M | Sell |
18,729
-180
| -1% | -$15.7K | 0.42% | 64 |
|
|
2020
Q3 | $1.64M | Sell |
18,909
-382
| -2% | -$33.1K | 0.46% | 60 |
|
|
2020
Q2 | $1.69M | Sell |
19,291
-450
| -2% | -$38.8K | 0.5% | 57 |
|
|
2020
Q1 | $1.63M | Sell |
19,741
-2,000
| -9% | -$178K | 0.58% | 45 |
|
|
2019
Q4 | $2.06M | Sell |
21,741
-600
| -3% | -$53.8K | 0.57% | 51 |
|
|
2019
Q3 | $1.94M | Sell |
22,341
-2,340
| -9% | -$210K | 0.52% | 57 |
|
|
2019
Q2 | $2.25M | Sell |
24,681
-3,951
| -14% | -$334K | 0.6% | 45 |
|
|
2019
Q1 | $2.47M | Sell |
28,632
-921
| -3% | -$73.9K | 0.69% | 41 |
|
|
2018
Q4 | $2.27M | Sell |
29,553
-937
| -3% | -$72.9K | 0.69% | 40 |
|
|
2018
Q3 | $2.35M | Sell |
30,490
-11,657
| -28% | -$862K | 0.61% | 47 |
|
|
2018
Q2 | $2.85M | Sell |
42,147
-6,292
| -13% | -$434K | 0.75% | 37 |
|
|
2018
Q1 | $3.51M | Sell |
48,439
-770
| -2% | -$58.6K | 0.92% | 26 |
|
|
2017
Q4 | $3.7M | Buy |
49,209
+558
| +1% | +$42.1K | 0.93% | 28 |
|
|
2017
Q3 | $3.74M | Sell |
48,651
-614
| -1% | -$46.4K | 0.99% | 25 |
|
|
2017
Q2 | $3.69M | Buy |
49,265
+1,507
| +3% | +$107K | 1.01% | 27 |
|
|
2017
Q1 | $3.18M | Sell |
47,758
-112
| -0.2% | -$7.46K | 0.91% | 27 |
|
|
2016
Q4 | $3.12M | Buy |
47,870
+357
| +0.8% | +$23.2K | 0.92% | 28 |
|
|
2016
Q3 | $3.36M | Buy |
47,513
+139
| +0.3% | +$10.1K | 1.01% | 23 |
|
|
2016
Q2 | $3.5M | Buy |
47,374
+837
| +2% | +$57.8K | 1.1% | 21 |
|
|
2016
Q1 | $3.02M | Buy |
46,537
+21
| +0% | +$1.43K | 1% | 21 |
|
|
2015
Q4 | $3.59M | Buy |
46,516
+167
| +0.4% | +$13.3K | 1.23% | 19 |
|
|
2015
Q3 | $3.82M | Buy |
46,349
+94
| +0.2% | +$8.37K | 1.36% | 15 |
|
|
2015
Q2 | $4.08M | Sell |
46,255
-2,959
| -6% | -$271K | 1.37% | 14 |
|
|
2015
Q1 | $4.35M | Sell |
49,214
-399
| -0.8% | -$35.4K | 1.38% | 14 |
|
|
2014
Q4 | $4.12M | Sell |
49,613
-446
| -0.9% | -$37K | 1.38% | 15 |
|
|
2014
Q3 | $4.22M | Hold |
50,059
| – | – | 1.46% | 11 |
|
|
2014
Q2 | $4.06M | Sell |
50,059
-1,655
| -3% | -$130K | 1.38% | 12 |
|
|
2014
Q1 | $3.94M | Sell |
51,714
-2,698
| -5% | -$197K | 1.36% | 11 |
|
|
2013
Q4 | $3.92M | Sell |
54,412
-708
| -1% | -$49.2K | 1.36% | 14 |
|
|
2013
Q3 | $3.79M | Sell |
55,120
-360
| -0.6% | -$23.8K | 1.43% | 13 |
|
|
2013
Q2 | $3.52M | Buy |
+55,480
| New | +$3.61M | 1.4% | 12 |
|
Other funds holding NVS
Baker Ellis Asset Management's NVS Position: Q1 2026 in Review
Baker Ellis Asset Management reduced its Novartis (NVS) stake by 2% in Q1 2026, selling an estimated $46K and leaving 14,950 shares worth $2.28M. The position accounts for 0.27% of the portfolio, ranked #77.
Baker Ellis Asset Management first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.35M in Q1 2015. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Baker Ellis Asset Management held 14,950 shares of Novartis worth $2.28M as of Q1 2026.
- Baker Ellis Asset Management sold 300 Novartis shares in Q1 2026, an estimated $46K.
- Novartis made up 0.27% of Baker Ellis Asset Management's portfolio in Q1 2026, its #77 holding.
- Baker Ellis Asset Management first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Baker Ellis Asset Management's Novartis position peaked at $4.35M in Q1 2015.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Baker Ellis Asset Management's 13F filing for Q1 2026, filed 17 Apr 2026.